| Steven E Roser, MD | |
|
600 N Robbins Rd, Ste 100, Boise, ID 83702-4566 | |
| (208) 383-0201 | |
| (208) 489-4300 |
| Full Name | Steven E Roser |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 32 Years |
| Location | 600 N Robbins Rd, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992716872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0004X | Orthopaedic Surgery - Foot And Ankle Surgery | M-7376 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
Isis Pharmaceuticals, Inc. announced today it has initiated a Phase 1 study of ISIS 353512, an antisense drug that inhibits the production of C-reactive protein (CRP). CRP levels are frequently elevated in patients with a variety of diseases including cardiovascular disease, Crohn's disease, rheumatoid arthritis and end-stage renal disease.
The hot flashes and night sweats that most women experience early in menopause are not linked to increased levels of cardiovascular disease risk markers unless the symptoms persist or start many years after menopause begins. These new study results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
The hearts and brains of babies born with congenital heart disease are not the only organs affected by this common medical condition.
Researchers have uncovered new information that may begin to explain why many African-American women are more likely to be diagnosed with aggressive, often deadly forms of breast cancer, which strengthens the evidence that increased dietary folate intake may prove to be an effective strategy for reducing risk for the disease in African-American women.
STB Lifesaving Technologies® today announced that is has completed a successful pre-Investigational New Drug (pre-IND) submission to the U.S. Food and Drug Administration (FDA) for its lead product, the Fibrin Adhesive STat®, or (FAST®) dressing.
› Verified 7 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
Isis Pharmaceuticals, Inc. announced today it has initiated a Phase 1 study of ISIS 353512, an antisense drug that inhibits the production of C-reactive protein (CRP). CRP levels are frequently elevated in patients with a variety of diseases including cardiovascular disease, Crohn's disease, rheumatoid arthritis and end-stage renal disease.
The hot flashes and night sweats that most women experience early in menopause are not linked to increased levels of cardiovascular disease risk markers unless the symptoms persist or start many years after menopause begins. These new study results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
The hearts and brains of babies born with congenital heart disease are not the only organs affected by this common medical condition.
Researchers have uncovered new information that may begin to explain why many African-American women are more likely to be diagnosed with aggressive, often deadly forms of breast cancer, which strengthens the evidence that increased dietary folate intake may prove to be an effective strategy for reducing risk for the disease in African-American women.
STB Lifesaving Technologies® today announced that is has completed a successful pre-Investigational New Drug (pre-IND) submission to the U.S. Food and Drug Administration (FDA) for its lead product, the Fibrin Adhesive STat®, or (FAST®) dressing.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven E Roser, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2222 | Steven E Roser, MD 600 N Robbins Rd, Ste 100, Boise, ID 83702-4566 Ph: (208) 383-0201 |
News Archive
Isis Pharmaceuticals, Inc. announced today it has initiated a Phase 1 study of ISIS 353512, an antisense drug that inhibits the production of C-reactive protein (CRP). CRP levels are frequently elevated in patients with a variety of diseases including cardiovascular disease, Crohn's disease, rheumatoid arthritis and end-stage renal disease.
The hot flashes and night sweats that most women experience early in menopause are not linked to increased levels of cardiovascular disease risk markers unless the symptoms persist or start many years after menopause begins. These new study results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
The hearts and brains of babies born with congenital heart disease are not the only organs affected by this common medical condition.
Researchers have uncovered new information that may begin to explain why many African-American women are more likely to be diagnosed with aggressive, often deadly forms of breast cancer, which strengthens the evidence that increased dietary folate intake may prove to be an effective strategy for reducing risk for the disease in African-American women.
STB Lifesaving Technologies® today announced that is has completed a successful pre-Investigational New Drug (pre-IND) submission to the U.S. Food and Drug Administration (FDA) for its lead product, the Fibrin Adhesive STat®, or (FAST®) dressing.
› Verified 7 days ago
Tracye Jean-marie Lawyer, MD, PHD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8950 W Emerald St Ste 168, Boise, ID 83704 Phone: 208-321-1209 Fax: 208-321-1211 | |
Dustin I Judd, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Robbins Rd, Suite 100, Boise, ID 83702 Phone: 208-383-0201 | |
Dr. Michael Glover, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 500 W Fort St, Mail Code #112, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1082 | |
Jeffrey D Smith, PA C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7979 W Rifleman St, Boise, ID 83704 Phone: 208-989-0598 | |
Howard A King, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 N Robbins Rd, Ste 100, Boise, ID 83702 Phone: 208-383-0201 Fax: 208-489-4300 | |
Dr. Jeffrey Glenn Hessing, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8854 W Emerald St, Suite 140, Boise, ID 83704 Phone: 208-327-4790 Fax: 208-367-4888 | |
Dr. Kirk J Lewis, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1188 University Dr, Boise, ID 83706 Phone: 208-336-8250 Fax: 208-345-9514 |